Educational Intervention for Early-Stage Cancer Care Coordination
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational intervention rather than medication changes.
What data supports the effectiveness of the Educational Intervention for Early-Stage Cancer Care Coordination treatment?
The research highlights the importance of patient education and care coordination in cancer treatment, showing that educational interventions can improve patients' understanding and confidence in managing their care. This suggests that similar educational tools, like the Table-based Educational Intervention Tool, may help patients better navigate their cancer treatment and improve their overall care experience.12345
Is the Educational Intervention for Early-Stage Cancer Care Coordination safe for humans?
The research articles reviewed do not provide specific safety data for the Educational Intervention for Early-Stage Cancer Care Coordination or its related names. However, they highlight the importance of patient education in cancer care, which generally improves patient satisfaction and outcomes without indicating any safety concerns.26789
How is the Table-based Educational Intervention treatment different from other treatments for early-stage cancer care coordination?
What is the purpose of this trial?
Care Coordination is an essential component of cancer care delivery. Many patients experience poor care coordination. In this study, we hypothesize that provision of a video educational intervention to teach patients about cancer, care coordination and self-advocacy will improve patients' perception of care coordination. Cancer patients with early stage disease scheduled to receive adjuvant therapy, and who reside in a rural area, will be enrolled onto the study. Patients will be randomized to receive a table-based educational intervention tool initially (arm1) or after 4 months of therapy (arm2). Assessment of cancer knowledge, self-advocacy and care coordination will be obtained at baseline and after 4-6 months.
Eligibility Criteria
This trial is for adults over 18 living in rural Vermont with early-stage (I, II, or III) breast, lung, or colon cancer who are about to start or have just started adjuvant chemotherapy. They must understand English and cannot have had chemotherapy for another cancer within the last three years.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline survey instruments to assess cancer knowledge, self-advocacy, and care coordination
Educational Intervention
Participants receive a video-based educational intervention either upfront or after 4 months of therapy
Follow-up Assessment
Participants complete follow-up surveys to reassess cancer knowledge, self-advocacy, and care coordination
Follow-up
Participants are monitored for changes in perception of care coordination and self-advocacy after the intervention
Treatment Details
Interventions
- Table-based Educational Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Vermont Medical Center
Lead Sponsor